These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies. Li Y; Li J; Liu Y; Shi Z; Liu H; Wei Y; Yang L Gene Ther; 2019 Jun; 26(6):264-276. PubMed ID: 31110296 [TBL] [Abstract][Full Text] [Related]
15. Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy. Liu Y; Siriwon N; Rohrs JA; Wang P Curr Pharm Des; 2015; 21(22):3248-56. PubMed ID: 26027561 [TBL] [Abstract][Full Text] [Related]
17. Intrinsic Differential Scanning Fluorimetry for Fast and Easy Identification of Adeno-Associated Virus Serotypes. Rieser R; Penaud-Budloo M; Bouzelha M; Rossi A; Menzen T; Biel M; Büning H; Ayuso E; Winter G; Michalakis S J Pharm Sci; 2020 Jan; 109(1):854-862. PubMed ID: 31639391 [TBL] [Abstract][Full Text] [Related]
18. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids. Chamberlain K; Riyad JM; Weber T Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051 [TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. Warrington KH; Gorbatyuk OS; Harrison JK; Opie SR; Zolotukhin S; Muzyczka N J Virol; 2004 Jun; 78(12):6595-609. PubMed ID: 15163751 [TBL] [Abstract][Full Text] [Related]